Trazodone

Basic Trazodone Information

• INN (International Nonproprietary Name): Trazodone
• Brand Names Available In United Kingdom: Desyrel (worldwide); Donaren (multiple); Trittico, Trittico AC, Trittico retard, Trittico XR (various European countries); Trazolan; Trazone; Trazonil; Triticum; Tronsalan; Sideril; Codipzona; Oleptro; other brands listed internationally (see Drugs.com/International).
• ATC Code: N06AX05
• Forms & Dosages: Immediate‑release tablets 50mg, 100mg (round, scored or unscored); extended‑release tablets 75mg, 100mg, 150mg (labelled retard/CR/XR); prolonged‑release tabs 75mg, 150mg; other forms rarely marketed.
• Manufacturers In United Kingdom: Intas Pharma (listed with presence in India and UK); other major global suppliers include Angelini Group, Mylan, Gonane Pharma, Global Pharma Tek, Shandong Octagon, TAPI, Fermion.
• Registration Status In United Kingdom: not specified
• OTC / Rx Classification: Prescription Only Medicine (Rx) in all markets.

Demand Drivers And Patient Perspectives

What pushes people to ask for trazodone at the counter or online?

Off‑label use for insomnia is a major driver of demand, with GPs, psychiatrists and private sleep clinics commonly prescribing trazodone because of its sedating profile.

Many patients reach out after secondary‑care referrals where trazodone is started as a sleep aid or as an antidepressant in outpatient follow‑up.

Patients often say trazodone helps them get to sleep faster, but report variable daytime sedation and morning drowsiness.

Common pharmacy enquiries include concerns about driving, mixing with alcohol and whether morning drowsiness is normal.

NHS prescribing routes differ locally — hospital outpatient initiation, GP repeat prescriptions after secondary‑care stabilisation or private prescriptions via online consultations are all encountered.

Regional UK nuances matter: prescription charge exemptions in Scotland, Wales and Northern Ireland affect demand for private supply and OTC support services.

Growth in online pharmacies and electronic prescriptions has increased access and raised counselling workload for community pharmacists at chains such as Boots, LloydsPharmacy and Superdrug.

Patient‑Reported Pros: improved sleep onset; low abuse potential.

Patient‑Reported Cons: morning drowsiness; dizziness; rare worrying side effects.

Common Patient Questions For Pharmacy Staff:

• Will trazodone make me feel sleepy in the morning?
• Can I drink alcohol while taking trazodone?
• Is it safe to drive after one night on trazodone?
• How quickly will it help my mood or sleep?

INN, ATC And Common Forms

Which formulations should pharmacists expect on stock lists?

Trazodone is the International Nonproprietary Name (INN) and sits under ATC code N06AX05, categorised among other antidepressants.

Two principal types of oral tablets are used: immediate‑release (IR) and extended/prolonged‑release (XR/PR/CR), chosen to balance nocturnal sedation and daytime antidepressant activity.

Typical immediate‑release strengths are 50mg and 100mg tablets, while extended‑release strengths often include 75mg, 100mg and 150mg and may be labelled retard, CR or XR.

Pharmacists should note excipient differences and whether tablets are scored for dose flexibility before advising on splitting.

Quick Definitions:

• INN: International Nonproprietary Name — trazodone.
• ATC: Anatomical Therapeutic Chemical code — N06AX05.
• IR vs XR: Immediate‑release tablets deliver dose quickly; extended‑release provide prolonged plasma concentration.
• PR: Prolonged release; commonly used in European brands such as Trittico retard.

Brand Availability And Supply Chain

Which brands and suppliers should procurement teams watch for?

Desyrel is the best‑known worldwide brand, and Trittico and its retard/XR lines are marketed across many European countries.

Other brand names include Donaren, Trazolan, Trazone, Trazonil, Triticum, Tronsalan and Sideril depending on the market.

Major manufacturers relevant for sourcing include Angelini Group, Intas Pharma, Mylan, Gonane Pharma, Global Pharma Tek, Shandong Octagon, TAPI and Fermion.

For UK community and online pharmacies, always order through authorised distributors and verify MHRA licensing and batch documentation before dispensing.

Supply‑Chain Notes:

• Periodic shortages can occur due to reliance on overseas API suppliers.
• Parallel imports and branded generics may require extra label checks and patient counselling on appearance changes.

UK/EU Regulatory Picture And Prescription Status

Is trazodone prescription‑only and where to check for product specifics?

Trazodone is a prescription‑only medicine across markets and is approved by major regulators such as the EMA and FDA for major depressive disorder.

Pharmacies must consult the MHRA licence particulars and the specific product SPC and PIL for authorised indications and dosing instructions before dispensing.

Different formulations may have differing authorised indications; for example, some extended‑release products carry distinct labelling across countries.

Online pharmacy services must perform MHRA‑required dispensing checks, maintain pharmacy medicine records and validate prescriptions securely, including electronic prescriptions.

Regulatory Quick Facts:

• Prescription Status: Prescription Only Medicine (Rx).
• Key Approvals: EMA and FDA approvals for major depressive disorder.
• Where To Check: MHRA product licence, manufacturer SPC and PIL.

Licensed Indications And Clinical Uses Commonly Encountered

When is trazodone used and what doses should pharmacists expect to see?

Licensed primary indication is major depressive disorder, where trazodone acts as an antidepressant with serotonin reuptake inhibition and 5‑HT2 antagonism.

Insomnia is a widespread off‑label use because trazodone’s sedating properties help sleep continuity for many patients.

Standard dosing for depression typically starts at 75–150 mg/day in divided doses and can be titrated up to 400 mg/day in outpatient practice, with inpatient doses reported up to 600 mg/day.

Insomnia doses are generally lower, commonly 25–100 mg at bedtime.

Off‑label insomnia prescribing should have documented rationale, patient consent and appropriate monitoring documented in records.

How To Start, Titrate And Stop Safely

How should trazodone be started and what practical advice helps patients stick to therapy?

For depression start low and titrate slowly; common initial outpatient ranges are 75–150 mg/day in divided doses with upward titration as tolerated.

The usual maximum adult dose is 400 mg/day, with inpatient dosing reaching up to 600 mg/day in specialist settings.

For insomnia a single low bedtime dose of 25–100 mg is commonly used.

Practical counselling points include taking with or after food to reduce nausea and avoiding splitting extended‑release tablets unless the SPC permits it.

Missed dose advice: take when remembered unless near the next dose and do not double up.

On stopping, taper gradually to reduce withdrawal risk.

Overdose is a medical emergency; symptoms include marked sedation, arrhythmias, respiratory depression, seizures and priapism and require urgent referral.

NHS Vs Private Supply, Online Ordering And Cost Factors

How do patients obtain trazodone and what costs should they expect?

Trazodone is prescription‑only and is dispensed on NHS prescriptions or private prescriptions including electronic prescriptions from accredited online consultations.

NHS prescribing commonly follows secondary‑care initiation or primary‑care management and local formularies may list preferred generics or brands.

Prescription charges apply in England unless exempt; Scotland, Wales and Northern Ireland have abolished routine prescription charges which affects private market demand.

In our online pharmacy, trazodone is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Checklist For E‑Prescriptions

• Validate prescriber details and electronic signature.
• Confirm indication, dose and formulation (IR vs XR).
• Record counselling and supply in pharmacy records.

Key Messages For Patients And Carers

What must patients understand before leaving with trazodone?

Sleep benefit may be rapid but antidepressant effects generally take several weeks to appear, with review at 2–4 weeks advised.

Common adverse effects are sedation, dizziness, dry mouth, nausea and constipation, and patients should expect possible morning drowsiness especially at higher bedtime doses.

Warn patients not to drive or operate machinery until they know how trazodone affects them.

Advise against alcohol and concomitant CNS depressants because these increase sedation and respiratory risk.

Elderly patients need explicit advice about orthostatic hypotension and fall risk and to rise slowly from sitting or lying positions.

Dispense‑Check For Pharmacy Staff:

• Confirm indication and document off‑label insomnia consent when appropriate.
• Review concomitant medicines for interactions and check pregnancy/breastfeeding status.
• Provide the PIL, dosing schedule and record counselling in the patient medication record.

Red‑Flag: Seek immediate A&E for priapism (prolonged erection), severe chest pain, sudden fainting or signs of serotonin syndrome.

High‑Risk Combinations And Clinical Cautions

Which drug combos must trigger extra checks or refusal to dispense?

Absolute contraindications include known hypersensitivity to trazodone, recent myocardial infarction and acute intoxication with alcohol or other CNS depressants.

Major interaction risks are co‑administration with MAOIs (risk of serotonin syndrome), concurrent serotonergic drugs (SSRIs, SNRIs, triptans) and strong CYP3A4 inhibitors or inducers altering plasma levels.

QT‑prolonging medicines may increase arrhythmia risk when combined with trazodone, so cardiac history and concomitant therapy must be checked.

Anticholinergic and antihypertensive medicines can magnify orthostatic hypotension and sedation.

Always perform medication reconciliation on repeats and consult the SPC for product‑specific contraindications.

Baseline And Follow‑Up Checks Pharmacies Should Prompt

What monitoring should pharmacists encourage during supply?

Baseline checks include a current medicines list, alcohol intake, pregnancy and breastfeeding status, cardiac history and seizure history.

Prompt GPs or specialists to monitor for worsening depression, emergent suicidality and hyponatraemia, especially in elderly patients or those on diuretics.

Consider ECG if there are cardiac risk factors or concomitant QT‑prolonging drugs, and electrolytes if clinically indicated.

Pharmacists should triage red‑flag symptoms such as severe dizziness, syncope, chest pain, priapism or signs of serotonin syndrome to emergency services.

Report suspected adverse drug reactions via the Yellow Card Scheme to maintain post‑marketing surveillance.

Red‑Flag Checklist:

• Prolonged painful erection — immediate A&E.
• Sudden severe dizziness, fainting or chest pain — emergency services.
• Mental state worsening or suicidal thoughts — urgent clinical review.

Elderly, Children, Pregnancy And Hepatic/Renal Impairment

How should trazodone be adjusted for vulnerable populations?

Children: safety and efficacy are not established and trazodone is generally not recommended for paediatric depression unless specialist‑initiated.

Elderly: start low (for insomnia often 50 mg at bedtime), titrate slowly and monitor for orthostatic hypotension, sedation and falls.

Pregnancy and Breastfeeding: weigh risks and benefits and liaise with obstetric and mental‑health specialists before supply.

Hepatic and Renal Impairment: reduce starting dose and titrate cautiously because accumulation may occur; consult SPC for specific guidance.

Practical Pharmacy And Patient Handling

How should trazodone be stored, transported and returned?

Store trazodone at room temperature, 15–30°C, in the original packaging protected from moisture and light.

Rotate stock by expiry date and monitor MHRA batch recall notices as part of routine pharmacy practice.

For home deliveries use secure, temperature‑stable packaging and document chain of custody for prescription medicines.

Advise patients to retain PILs and return or dispose of outdated tablets via pharmacy returns schemes rather than household waste.

Be mindful that scored tablets and extended‑release formulations have different handling instructions — do not advise splitting XR tablets unless SPC allows.

Dispensing Staff Checklist:

• Check storage temperature (15–30°C) and expiry dates.
• Confirm product type (IR vs XR) and patient instructions.
• Advise on safe disposal and returns.

When To Choose Trazodone And Viable Alternatives

Which therapies compete with trazodone and when is switching appropriate?

Trazodone competes with SSRIs such as sertraline, escitalopram and fluoxetine for depression, and with sedating antidepressants like mirtazapine or doxepin for insomnia.

Choice depends on symptom profile: SSRIs are often preferred for core depressive symptoms and anxiety, whereas trazodone may be chosen when sleep continuity and nocturnal sedation are priorities.

Trazodone has low abuse potential compared with benzodiazepines but carries unique risks such as orthostatic hypotension and very rare priapism.

Recommend cross‑taper strategies per SPC and specialist advice for complex polypharmacy or cardiac risk.

Optimising The Online/On‑Shelf Product Page For Conversion And Safety

What must a compliant and effective product page include?

Use a clear product title such as “Trazodone 50 mg/100 mg Tablets — INN” and provide brand options, strength and pack size selectors with a prominent prescription requirement badge.

Display MHRA licence summary, quick links to SPC and PIL, pricing (NHS vs private), availability and a clear CTA to “Request Prescription” or “Arrange Consultation” linked to an accredited pharmacist service.

Include mandatory safety elements such as red‑flag warnings for priapism and serotonin syndrome, contraindications and storage instructions (15–30°C), and a Yellow Card reporting link.

Offer downloadable resources: PIL, dosing table and pharmacist counselling checklist for patients.

Compliance Checklist For Legal Review:

• Prescription only badge present and unambiguous.
• Links to SPC/PIL and MHRA licence available.
• Clear contraindication and red‑flag warnings displayed prominently.

Delivery Across United Kingdom